Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2001-06-18 M&A Activity
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
EVOTEC BioSystems AG english
M&A Activity Classification · 99% confidence The document is an 'Ad hoc announcement' dated June 18, 2001, detailing a strategic collaboration and the formation of a joint venture between EVOTEC BioSystems AG and MelTec GmbH concerning drug discovery services. This type of announcement, which details significant corporate actions like forming a joint venture, entering into a major service agreement, or making a material financial commitment (Euro 5 million upfront payment), is typically classified as a significant corporate event disclosure. Since it is not a standard periodic report (10-K, IR, ER), a management discussion (MDA), or a specific financing/share action (CAP, SHA, POS), it falls best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). It is a direct, material disclosure rather than a presentation (IP) or a transcript (CT).
2001-06-18 English
Ad hoc-Service: EVOTEC BioSystems AG KORREKTUR
Earnings Release Classification · 100% confidence The document is an 'Ad hoc-Service' announcement dated May 16, 2001, detailing the financial performance for the 'Erstes Quartal 2001' (First Quarter 2001). It provides key financial metrics like revenue, operating loss, net loss, and EBITDA for the period, along with business updates and outlook. This content structure—a brief announcement summarizing key figures for a specific interim period—aligns perfectly with the definition of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR) nor is it a transcript (CT) or a formal presentation (IP). Since it is a direct release of period results, ER is the most appropriate classification. Q1 2001
2001-05-16 German
Ad hoc-Service: EVOTEC BioSystems AG Dt./Engl.
Earnings Release Classification · 100% confidence The document is an 'Ad hoc-Mitteilung' (Ad hoc announcement) dated May 16, 2001, summarizing financial performance for the 'First Quarter 2001'. It explicitly details revenue, operating loss, EBITDA, and provides an outlook. This structure—a brief announcement highlighting key figures for a specific interim period (Q1)—is characteristic of an Earnings Release (ER), which provides initial highlights before a more comprehensive report (like an IR) might follow. Since it focuses on the immediate results announcement rather than a comprehensive period report (IR) or a full annual report (10-K), ER is the most appropriate classification. The length (6873 chars) is substantial but the format is that of a press release announcing results, not the full detailed report itself. Q1 2001
2001-05-16 German
Ad hoc-Service: EVOTEC BioSystems AG english
Regulatory Filings Classification · 100% confidence The document is a short 'Ad hoc announcement' dated April 26, 2001, detailing a services agreement between Evotec OAI and Serono regarding assay development and screening. This type of announcement, which reports on a specific business event (a contract signing) rather than routine financial results (ER, IR) or mandatory regulatory filings (10-K, AR), fits best under the general category for regulatory announcements or miscellaneous corporate news. Since it is not a Director's Dealing (DIRS), Capital Change (CAP), Dividend (DIV), or Management Change (MANG), and it is not a presentation (IP) or a transcript (CT), the most appropriate classification is the general regulatory filing/announcement category, RNS, as it is an 'Ad hoc-Service' announcement processed by DGAP.
2001-04-26 English
Ad hoc-Service: EVOTEC BioSystems AG english
Board/Management Information Classification · 100% confidence The document is an 'Ad hoc announcement' dated April 18, 2001, detailing 'key management changes' including the appointment of a new CEO (Jörn Aldag) and resignations/appointments to the Supervisory Board. This content directly relates to changes in the company's board of directors or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (3754 chars) is not indicative of a full report, but the content is specific enough to avoid the general 'RPA' or 'RNS' categories.
2001-04-18 English
Ad hoc-Service: EVOTEC BioSystems AG english
Regulatory Filings Classification · 100% confidence The document is an 'Ad hoc announcement' dated April 10, 2001, detailing a technology agreement signed between Evotec OAI and Celltech Group plc regarding VLiP technology. This type of announcement, which reports on a specific business development (a partnership/agreement) outside of routine financial reporting (like earnings or annual reports), fits best under the general category for regulatory announcements that do not fit elsewhere. Since it is not a formal financial report (10-K, IR, ER), a management change (MANG), or a capital event (CAP, SHA), it is classified as a general Regulatory Filing (RNS). The length is short, but the content is substantive news, not just a notice of publication.
2001-04-10 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.